| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RhoGAP | 7.28e-03 | 63 | 38 | 2 | PF00620 | |
| Domain | RHOGAP | 7.51e-03 | 64 | 38 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 7.51e-03 | 64 | 38 | 2 | IPR000198 | |
| Domain | - | 7.51e-03 | 64 | 38 | 2 | 1.10.555.10 | |
| Domain | CH | 7.73e-03 | 65 | 38 | 2 | SM00033 | |
| Domain | CH | 8.92e-03 | 70 | 38 | 2 | PF00307 | |
| Domain | IQ | 9.17e-03 | 71 | 38 | 2 | PF00612 | |
| Domain | - | 9.17e-03 | 71 | 38 | 2 | 1.10.418.10 | |
| Domain | CH | 9.67e-03 | 73 | 38 | 2 | PS50021 | |
| Domain | - | 9.80e-03 | 218 | 38 | 3 | 1.10.10.10 | |
| Domain | CH-domain | 1.02e-02 | 75 | 38 | 2 | IPR001715 | |
| Domain | IQ | 1.18e-02 | 81 | 38 | 2 | SM00015 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RECQL PNPLA8 NOP58 EIF3B RPL38 NHP2 RNPS1 ZC3H15 VPS13C NOC3L | 4.53e-06 | 1425 | 41 | 10 | 30948266 |
| Pubmed | 7.57e-06 | 106 | 41 | 4 | 12429849 | ||
| Pubmed | 2.13e-05 | 731 | 41 | 7 | 29298432 | ||
| Pubmed | ASPM SLC39A6 PNPLA8 TMEM131 NOP58 DEPDC1B ZC3H15 SYNE2 NOC3L | 4.73e-05 | 1487 | 41 | 9 | 33957083 | |
| Pubmed | 5.11e-05 | 568 | 41 | 6 | 37774976 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.44e-05 | 608 | 41 | 6 | 36089195 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.17e-04 | 410 | 41 | 5 | 26949251 | |
| Pubmed | Cell-fate determination by ubiquitin-dependent regulation of translation. | 1.22e-04 | 14 | 41 | 2 | 26399832 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 17903295 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.47e-04 | 430 | 41 | 5 | 38172120 | |
| Pubmed | 1.50e-04 | 87 | 41 | 3 | 12465718 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.56e-04 | 1353 | 41 | 8 | 29467282 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 2.01e-04 | 96 | 41 | 3 | 25948554 | |
| Pubmed | The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesis. | 2.81e-04 | 21 | 41 | 2 | 33852194 | |
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 3.62e-04 | 287 | 41 | 4 | 28712289 | |
| Pubmed | 4.45e-04 | 847 | 41 | 6 | 35850772 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 5.96e-04 | 139 | 41 | 3 | 25476789 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 6.11e-04 | 330 | 41 | 4 | 33301849 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 7.43e-04 | 150 | 41 | 3 | 30154076 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 7.53e-04 | 349 | 41 | 4 | 25665578 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 8.03e-04 | 1318 | 41 | 7 | 30463901 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 8.54e-04 | 361 | 41 | 4 | 30344098 | |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 8.80e-04 | 159 | 41 | 3 | 34578187 | |
| Pubmed | 9.07e-04 | 641 | 41 | 5 | 36057605 | ||
| Pubmed | 9.10e-04 | 971 | 41 | 6 | 33306668 | ||
| Pubmed | 9.85e-04 | 653 | 41 | 5 | 22586326 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 9.94e-04 | 1367 | 41 | 7 | 32687490 | |
| Pubmed | 1.05e-03 | 169 | 41 | 3 | 31462741 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.16e-03 | 678 | 41 | 5 | 30209976 | |
| GeneFamily | RNA binding motif containing | 2.73e-02 | 213 | 22 | 2 | 725 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CEP70 ASPM CCDC112 SLC39A6 RECQL VPS13C GCC2 SYNE2 TTLL7 NOC3L | 5.01e-08 | 656 | 41 | 10 | M18979 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ASPM ERICH1 SLC39A6 RECQL NOP58 EIF3B RNPS1 DEPDC1B ZC3H15 CXCL9 NOC3L | 7.28e-06 | 1407 | 41 | 11 | M14427 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.66e-06 | 311 | 40 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 9.84e-07 | 196 | 41 | 5 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 41 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-06 | 129 | 41 | 4 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-06 | 132 | 41 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.87e-05 | 172 | 41 | 4 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.87e-05 | 172 | 41 | 4 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 1.87e-05 | 172 | 41 | 4 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 174 | 41 | 4 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 174 | 41 | 4 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 174 | 41 | 4 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 174 | 41 | 4 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 174 | 41 | 4 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 176 | 41 | 4 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 177 | 41 | 4 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 178 | 41 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.28e-05 | 181 | 41 | 4 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.28e-05 | 181 | 41 | 4 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.28e-05 | 181 | 41 | 4 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 2.71e-05 | 189 | 41 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 191 | 41 | 4 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-05 | 196 | 41 | 4 | fd756b247b2d8a291e8e71bec6f1e463d6557536 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.31e-05 | 199 | 41 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.31e-05 | 199 | 41 | 4 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class | 3.31e-05 | 199 | 41 | 4 | 0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.31e-05 | 199 | 41 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 3.37e-05 | 200 | 41 | 4 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 130 | 41 | 3 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-04 | 134 | 41 | 3 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 138 | 41 | 3 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.76e-04 | 138 | 41 | 3 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-04 | 150 | 41 | 3 | 6bdf9df586f348641a25a445e83a41e47e7f347e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 155 | 41 | 3 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.42e-04 | 162 | 41 | 3 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-04 | 163 | 41 | 3 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-04 | 163 | 41 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-04 | 164 | 41 | 3 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 167 | 41 | 3 | d15168f46c1599d9fc68a05a7b822c4b439f2987 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 167 | 41 | 3 | 2812353ff66e76f10bd327ceb0e6b009502a5258 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 4.91e-04 | 168 | 41 | 3 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 169 | 41 | 3 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 169 | 41 | 3 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 169 | 41 | 3 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-04 | 169 | 41 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.08e-04 | 170 | 41 | 3 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.17e-04 | 171 | 41 | 3 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.26e-04 | 172 | 41 | 3 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 173 | 41 | 3 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.53e-04 | 175 | 41 | 3 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.53e-04 | 175 | 41 | 3 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.53e-04 | 175 | 41 | 3 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.53e-04 | 175 | 41 | 3 | 654299df246debe0a5b12f0d9568eb828bb94bb9 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.53e-04 | 175 | 41 | 3 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.53e-04 | 175 | 41 | 3 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-04 | 175 | 41 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-04 | 175 | 41 | 3 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.62e-04 | 176 | 41 | 3 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 5.62e-04 | 176 | 41 | 3 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 5.72e-04 | 177 | 41 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-04 | 177 | 41 | 3 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 5.72e-04 | 177 | 41 | 3 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.72e-04 | 177 | 41 | 3 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.72e-04 | 177 | 41 | 3 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-04 | 177 | 41 | 3 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-04 | 177 | 41 | 3 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-04 | 177 | 41 | 3 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-04 | 178 | 41 | 3 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.91e-04 | 179 | 41 | 3 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-04 | 180 | 41 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-04 | 180 | 41 | 3 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 6.00e-04 | 180 | 41 | 3 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.10e-04 | 181 | 41 | 3 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 182 | 41 | 3 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.30e-04 | 183 | 41 | 3 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 6.30e-04 | 183 | 41 | 3 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.40e-04 | 184 | 41 | 3 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 6.50e-04 | 185 | 41 | 3 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-04 | 185 | 41 | 3 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | (101)_plasma|World / immune cells in Peripheral Blood (logTPM normalization) | 6.60e-04 | 186 | 41 | 3 | 16267994c9ef1fb7118c4c665cbc96979ec2b703 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 6.60e-04 | 186 | 41 | 3 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| Drug | Clorgyline | 1.25e-05 | 168 | 41 | 5 | ctd:D003010 | |
| Disease | Breast Cancer, Familial | 7.61e-04 | 30 | 40 | 2 | C0346153 | |
| Disease | mean platelet volume | 2.36e-03 | 1020 | 40 | 6 | EFO_0004584 | |
| Disease | Malignant neoplasm of breast | 3.05e-03 | 1074 | 40 | 6 | C0006142 | |
| Disease | cutaneous melanoma, hair color | 3.22e-03 | 62 | 40 | 2 | EFO_0000389, EFO_0003924 | |
| Disease | FEV/FEC ratio | 5.86e-03 | 1228 | 40 | 6 | EFO_0004713 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TISKNKKRKLKKKQQ | 156 | Q86X53 | |
| QIKQIKKDLKKYSKI | 716 | P55884 | |
| KKESIQIWKTKKQQK | 221 | Q8NEF3 | |
| RKNTPKQKEKKIKKQ | 521 | P29374 | |
| SNKEKKKKLKQFQKS | 466 | Q8WUY9 | |
| KIIQEKYRANKKKQK | 2581 | Q8IZT6 | |
| ETAKKKKQQQLQKLK | 76 | Q8IWA6 | |
| QKKTITQIVKDKKKQ | 106 | Q8HWS3 | |
| EGIKKKKQQKIKNIL | 516 | Q9UM07 | |
| GKINKQLKKVLKKIV | 66 | Q9Y2X3 | |
| ILKKINKAIVSKKNK | 91 | P07093 | |
| FQQKALKQTKQKKSK | 6 | Q8IZS5 | |
| EKNFTKLAKKQKQLK | 246 | A0A1B0GVN3 | |
| QQVKKLEKALKKNVK | 301 | Q8NHQ1 | |
| EKNTKIKQLLVKTKK | 1216 | Q8IWJ2 | |
| YQKQKLEIKGKKQKR | 456 | Q17RS7 | |
| KTLQKKKQQKIKEKL | 26 | Q8IXL9 | |
| IKKWEKQVSQKKKQK | 86 | Q07325 | |
| EKLQKNNITKKKKLV | 1346 | Q6ZMW3 | |
| LNAVLQKKKDIKFKK | 546 | O14815 | |
| KLYKCIKKAVKQKQI | 46 | Q9NX24 | |
| KVKLENKLKNKQFKQ | 21 | Q8WTT2 | |
| KQKNIKQAIKSLKKY | 146 | Q9NP80 | |
| KIKYNNNFKIKNKIK | 116 | Q9P2F6 | |
| VKKKSLLGVKENNKK | 6 | Q15287 | |
| VKQGNYVKVKKILKK | 31 | Q8IWB6 | |
| QEKKAQLKIYKKFLK | 2176 | Q8WXH0 | |
| EKAQKLLQKVKKVFK | 191 | O75354 | |
| KSVKIKKNKDNVKFK | 21 | P63173 | |
| FLISQKKKLLKKQEQ | 571 | Q9BXS9 | |
| LTLIKQFKDKKKKNQ | 441 | Q13433 | |
| IQKKKVLTKKIKQCL | 36 | P46063 | |
| KQQQRKEKLAAKKKL | 71 | Q9H9Y2 | |
| QVKQKSKKLLNIKKE | 1461 | Q92545 | |
| KKKNIFTKNKVQLKI | 2806 | Q709C8 | |
| LKLKKVNKAEKVLKQ | 806 | Q8NDW8 | |
| KKLKLLQKKQVQIQK | 181 | Q8N3L3 | |
| VKKRKQTSKNNIEKK | 216 | Q504Y3 | |
| LKNKKGAKQQKFIKA | 31 | Q8WU90 | |
| KQQVVKFLIKKKANL | 321 | Q6S545 | |
| FQNYVKELKKKRKQK | 141 | Q6ZT98 |